Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 10/20 | 0.39 |
| ▸ | ADH1C | P00326 | 8/20 | 0.39 |
| ▸ | ADH1B | P00325 | 4/20 | 0.39 |
| ▸ | ADH4 | P08319 | 3/20 | 0.39 |
| ▸ | ADH7 | P40394 | 2/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
| ▸ | CES1 | P23141 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1684034 | 1.00 | ADH1A (0.39) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL1684030 | 1.00 | ADH1A (0.39) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL2859214 | 1.00 | ADH1A (0.39) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL1684031 | 1.00 | ADH1A (0.39) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL887172 | 0.90 | ADH1A (0.36) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL887171 | 0.90 | ADH1A (0.36) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL2855078 | 0.90 | ADH1A (0.36) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL887136 | 0.90 | ADH1A (0.36) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL887170 | 0.90 | ADH1A (0.36) | ADH1AADH1CADH1BADH4ADH7 | |
| SCHEMBL59918 | 0.87 | ADH1A (0.41) | ADH1AADH1CADH1BADH4ADH7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2200957-B2 | HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-14 | — | — | EP | claimed |
| EP-2200957-B1 | HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-12-26 | — | — | EP | claimed |
| US-8304583-B2 | Hydrogenation of aliphatic dialdehydes to aliphatic diols | DOW GLOBAL TECHNOLOGIES LLC | 2012-11-06 | — | — | US | claimed |
| US-20110098514-A1 | HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2011-04-28 | — | — | US | claimed |
| EP-2200957-B2 | HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2016-09-14 | — | — | EP | disclosed |
| EP-2200957-B1 | HYDROGENATION OF ALICYCLIC DIALDEHYDES TO ALICYCLIC DIOLS | DOW GLOBAL TECHNOLOGIES LLC (US) | 2012-12-26 | — | — | EP | disclosed |
| US-8304583-B2 | Hydrogenation of aliphatic dialdehydes to aliphatic diols | DOW GLOBAL TECHNOLOGIES LLC | 2012-11-06 | — | — | US | disclosed |
| EP-2348015-A2 | PREPARATION OF CYANO-ALIPHATIC ALDEHYDES | Dow Global Technologies LLC (US) | 2011-07-27 | — | — | EP | disclosed |
| US-20110098514-A1 | HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION | 2011-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110098514-A1 | HYDROGENATION OF ALIPHATIC DIALDEHYDES TO ALIPHATIC DIOLS | ADH1C, ADH1A, DHCR24 | ADH1A 2/4885ADH1C 1/4885ADH1B 18/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.